BUY Eternal Limited — Rajesh Palviya, Axis Securities
byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))21 Aug 2026via ET Now (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Eternal shares decline ahead of MSCI rebalancing, inflows worth nearly $700 million expected
NewsCnbc-Tv18·31 Aug · today
1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·26 Aug · 5d ago
Eternal, Eicher Motors Among Top Bets In Ambit's Multi-Cap Pricing Prowess Fund
NewsNdtv-Profit·24 Aug · 1w ago
Q1 Earnings: ICICI Bank, Eternal, Titan Included In Morgan Stanley's Eight Bottom-Up Picks — Check Full List, Target Prices
NewsNdtv-Profit·20 Aug · 2w ago
2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·20 Aug · 2w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Eternal
- BUY — Kush Bohra23 Oct 2026 · ~2 weeks · target ₹330 · Active
- BUY — Siddharth Khemka, Motilal Oswal23 Oct 2026 · ~1 year · target ₹420 · Active
- BUY — Arun Kumar Mantri23 Oct 2026 · ~2 weeks · target ₹325 · Active
- BUY — IDBI Capital23 Oct 2026 · ~2 weeks · target ₹322 · Active
- BUY — Shivangi Sarda, Motilal Oswal23 Oct 2026 · ~1 year · target ₹325 · Active
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

